-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.00212.5% Upside
Acumen Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Acumen Pharmaceuticals, Inc.?
Acumen Pharmaceuticals, Inc. has been rated by research analysts at Citigroup in the past 90 days.